Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-04-07
DOI
10.1038/srep23179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab
- (2015) Pengkai Ma et al. International Journal of Nanomedicine
- Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand
- (2015) Hitesh Kulhari et al. MEDICINAL RESEARCH REVIEWS
- Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer
- (2015) Hitesh Kulhari et al. Nanomedicine
- Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel
- (2014) Hitesh Kulhari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Dendrimer–TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes
- (2014) Deep Pooja et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Trastuzumab for patients with HER2 positive breast cancer: Delivery, duration and combination therapies
- (2013) Ana Catarina Pinto et al. BREAST
- Treatment of HER2-positive breast cancer
- (2013) Maria Cristina Figueroa-Magalhães et al. BREAST
- Time for more optimism in metastatic breast cancer?
- (2013) Elżbieta Senkus et al. CANCER TREATMENT REVIEWS
- Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation
- (2013) Hitesh Kulhari et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel
- (2013) Anandhkumar Raju et al. Expert Opinion on Drug Delivery
- Docetaxel-Loaded Solid Lipid Nanoparticles: Preparation, Characterization, In Vitro, and In Vivo Evaluations
- (2013) Navid Mosallaei et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacokinetic and Pharmacodynamic Studies of Poly(amidoamine) Dendrimer Based Simvastatin Oral Formulations for the Treatment of Hypercholesterolemia
- (2013) Hitesh Kulhari et al. MOLECULAR PHARMACEUTICS
- Trastuzumab Labeled to High Specific Activity with 111In by Conjugation to G4 PAMAM Dendrimers Derivatized with Multiple DTPA Chelators Exhibits Increased Cytotoxic Potency on HER2-Positive Breast Cancer Cells
- (2013) Conrad Chan et al. PHARMACEUTICAL RESEARCH
- Selective Anti-Proliferation of HER2-Positive Breast Cancer Cells by Anthocyanins Identified by High-Throughput Screening
- (2013) Weihua Liu et al. PLoS One
- Synthesis and In Vivo Pharmacokinetic Evaluation of Degradable Shell Cross-Linked Polymer Nanoparticles with Poly(carboxybetaine) versus Poly(ethylene glycol) Surface-Grafted Coatings
- (2012) Ang Li et al. ACS Nano
- Efficient Intracellular Delivery of Camptothecin by Silica/Titania Hollow Nanoparticles
- (2012) Chanhoi Kim et al. CHEMISTRY-A EUROPEAN JOURNAL
- Docetaxel Nanotechnology in Anticancer Therapy
- (2012) Pengxiang Zhao et al. ChemMedChem
- Trastuzumab decorated methotrexate–human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells
- (2012) Azade Taheri et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy
- (2011) Geetanjali Arya et al. Nanomedicine-Nanotechnology Biology and Medicine
- Performance evaluation of PAMAM dendrimer based simvastatin formulations
- (2010) Hitesh Kulhari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anionic Amino Acid Dendrimer−Trastuzumab Conjugates for Specific Internalization in HER2-Positive Cancer Cells
- (2010) Takuya Miyano et al. MOLECULAR PHARMACEUTICS
- Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel
- (2009) Si-Shen Feng et al. BIOMATERIALS
- The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator
- (2009) Ji-Young Kim et al. BIOMATERIALS
- Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: The effects of PEGylation degree and drug conjugation style
- (2009) Saijie Zhu et al. BIOMATERIALS
- Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
- (2009) Alvaro Moreno-Aspitia et al. MAYO CLINIC PROCEEDINGS
- Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation
- (2008) Isabel M. Steinhauser et al. BIOMATERIALS
- Dendrimers for enhanced drug solubilization
- (2008) Sonke Svenson et al. Nanomedicine
- HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb
- (2008) Rameshwer Shukla et al. NANOTECHNOLOGY
- Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer
- (2007) Bingfeng Sun et al. BIOMATERIALS
- Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
- (2007) Yiyun Cheng et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started